What amount sold does Bench7 Inc. report in Form D filings?

The latest linked filings report $100K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Bench7 Inc.'s most recent SEC filing?

Bench7 Inc.'s most recent Form D filing was on 2025-03-20.

How many investors does Bench7 Inc. have?

The most recent Form D filing lists 2 investor(s).

Bench7 Inc.

CIK: 0002062359·Biotechnology·BISMARCK, ND·Corporation·Founded 2024

Reported Sold

$100,000

Total Filings

Identified Offerings

Last Filed

Mar 20, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 20, 2025Form D — New notice

Reported sold: $100,000 · Target: $100,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$100,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Chris James Pearce

Related Person

Appears on 1 filing

John Persson

Related Person

Appears on 1 filing

Jesse Weiand

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 20, 2025	New	$100,000	$100,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Vertical Longevity Pharmaceuticals, Inc.

Biotechnology

Offering target: $110,000

Filed Sep 25, 2026